metastatic

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

December, 2024

metastatic

Nov 24, 2024, 04:47 | Blog

Zanidatamab is approved by US FDA based off Herizon BTC01

Oncology Brothers shared a post on X: "Zanidatamab (bispecific antibody against Her2) now US FDA…

Jul 12, 2024, 16:05 | Insight

Piotr Wysocki: Bone Pain and Survival Among Patients With mHSPC

Piotr Wysocki recently posted on LinkedIn: "Bone pain is linked to worse overall survival (OS) in…

Jul 29, 2023, 18:25 | Blog

How current research is addressing optimization of the use of ctDNA for improving outcomes in metastatic colorectal cancer - Andrea Sartore Bianchi

In the evolving molecular treatment landscape of metastatic colorectal cancer, the identification of druggable alterations…

Jul 21, 2023, 19:18 | Societies

ASCO has been awarded $11M of PCORI research funding to study CDK4/6 inhibitors dosing in older adults w metastatic breast cancer

In a post by ASCO on Twitter, it says, "We’re pleased to announce ASCO has…

All: 4 Posts: 1 - 100

'

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

'

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

'

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

'

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

'

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023